Our programme is a core part of our operations and our goal of helping women to fight the effects of HIV/AIDS by tackling poverty, which is a key driver of HIV/AIDS in Malawi and most parts of the world.
MASYAP part of community stakeholder process to trial new HIV prevention antibodies
The HIV Vaccine Trials Network (HPTN) and HIV Prevention Trials network are collaborating in doing a research/study to assess whether the anti-HIV antibody called VRC01 made from the laboratory may be able to prevent HIV infection in people who are